Cargando…
Molecular Mechanisms Underlying the Enhanced Analgesic Effect of Oxycodone Compared to Morphine in Chemotherapy-Induced Neuropathic Pain
Oxycodone is a μ-opioid receptor agonist, used for the treatment of a large variety of painful disorders. Several studies have reported that oxycodone is a more potent pain reliever than morphine, and that it improves the quality of life of patients. However, the neurobiological mechanisms underlyin...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3949760/ https://www.ncbi.nlm.nih.gov/pubmed/24618941 http://dx.doi.org/10.1371/journal.pone.0091297 |
_version_ | 1782306935623647232 |
---|---|
author | Thibault, Karine Calvino, Bernard Rivals, Isabelle Marchand, Fabien Dubacq, Sophie McMahon, Stephen B. Pezet, Sophie |
author_facet | Thibault, Karine Calvino, Bernard Rivals, Isabelle Marchand, Fabien Dubacq, Sophie McMahon, Stephen B. Pezet, Sophie |
author_sort | Thibault, Karine |
collection | PubMed |
description | Oxycodone is a μ-opioid receptor agonist, used for the treatment of a large variety of painful disorders. Several studies have reported that oxycodone is a more potent pain reliever than morphine, and that it improves the quality of life of patients. However, the neurobiological mechanisms underlying the therapeutic action of these two opioids are only partially understood. The aim of this study was to define the molecular changes underlying the long-lasting analgesic effects of oxycodone and morphine in an animal model of peripheral neuropathy induced by a chemotherapic agent, vincristine. Using a behavioural approach, we show that oxycodone maintains an optimal analgesic effect after chronic treatment, whereas the effect of morphine dies down. In addition, using DNA microarray technology on dorsal root ganglia, we provide evidence that the long-term analgesic effect of oxycodone is due to an up-regulation in GABA(B) receptor expression in sensory neurons. These receptors are transported to their central terminals within the dorsal horn, and subsequently reinforce a presynaptic inhibition, since only the long-lasting (and not acute) anti-hyperalgesic effect of oxycodone was abolished by intrathecal administration of a GABA(B) receptor antagonist; in contrast, the morphine effect was unaffected. Our study demonstrates that the GABA(B) receptor is functionally required for the alleviating effect of oxycodone in neuropathic pain condition, thus providing new insight into the molecular mechanisms underlying the sustained analgesic action of oxycodone. |
format | Online Article Text |
id | pubmed-3949760 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-39497602014-03-12 Molecular Mechanisms Underlying the Enhanced Analgesic Effect of Oxycodone Compared to Morphine in Chemotherapy-Induced Neuropathic Pain Thibault, Karine Calvino, Bernard Rivals, Isabelle Marchand, Fabien Dubacq, Sophie McMahon, Stephen B. Pezet, Sophie PLoS One Research Article Oxycodone is a μ-opioid receptor agonist, used for the treatment of a large variety of painful disorders. Several studies have reported that oxycodone is a more potent pain reliever than morphine, and that it improves the quality of life of patients. However, the neurobiological mechanisms underlying the therapeutic action of these two opioids are only partially understood. The aim of this study was to define the molecular changes underlying the long-lasting analgesic effects of oxycodone and morphine in an animal model of peripheral neuropathy induced by a chemotherapic agent, vincristine. Using a behavioural approach, we show that oxycodone maintains an optimal analgesic effect after chronic treatment, whereas the effect of morphine dies down. In addition, using DNA microarray technology on dorsal root ganglia, we provide evidence that the long-term analgesic effect of oxycodone is due to an up-regulation in GABA(B) receptor expression in sensory neurons. These receptors are transported to their central terminals within the dorsal horn, and subsequently reinforce a presynaptic inhibition, since only the long-lasting (and not acute) anti-hyperalgesic effect of oxycodone was abolished by intrathecal administration of a GABA(B) receptor antagonist; in contrast, the morphine effect was unaffected. Our study demonstrates that the GABA(B) receptor is functionally required for the alleviating effect of oxycodone in neuropathic pain condition, thus providing new insight into the molecular mechanisms underlying the sustained analgesic action of oxycodone. Public Library of Science 2014-03-11 /pmc/articles/PMC3949760/ /pubmed/24618941 http://dx.doi.org/10.1371/journal.pone.0091297 Text en © 2014 Thibault et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article Thibault, Karine Calvino, Bernard Rivals, Isabelle Marchand, Fabien Dubacq, Sophie McMahon, Stephen B. Pezet, Sophie Molecular Mechanisms Underlying the Enhanced Analgesic Effect of Oxycodone Compared to Morphine in Chemotherapy-Induced Neuropathic Pain |
title | Molecular Mechanisms Underlying the Enhanced Analgesic Effect of Oxycodone Compared to Morphine in Chemotherapy-Induced Neuropathic Pain |
title_full | Molecular Mechanisms Underlying the Enhanced Analgesic Effect of Oxycodone Compared to Morphine in Chemotherapy-Induced Neuropathic Pain |
title_fullStr | Molecular Mechanisms Underlying the Enhanced Analgesic Effect of Oxycodone Compared to Morphine in Chemotherapy-Induced Neuropathic Pain |
title_full_unstemmed | Molecular Mechanisms Underlying the Enhanced Analgesic Effect of Oxycodone Compared to Morphine in Chemotherapy-Induced Neuropathic Pain |
title_short | Molecular Mechanisms Underlying the Enhanced Analgesic Effect of Oxycodone Compared to Morphine in Chemotherapy-Induced Neuropathic Pain |
title_sort | molecular mechanisms underlying the enhanced analgesic effect of oxycodone compared to morphine in chemotherapy-induced neuropathic pain |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3949760/ https://www.ncbi.nlm.nih.gov/pubmed/24618941 http://dx.doi.org/10.1371/journal.pone.0091297 |
work_keys_str_mv | AT thibaultkarine molecularmechanismsunderlyingtheenhancedanalgesiceffectofoxycodonecomparedtomorphineinchemotherapyinducedneuropathicpain AT calvinobernard molecularmechanismsunderlyingtheenhancedanalgesiceffectofoxycodonecomparedtomorphineinchemotherapyinducedneuropathicpain AT rivalsisabelle molecularmechanismsunderlyingtheenhancedanalgesiceffectofoxycodonecomparedtomorphineinchemotherapyinducedneuropathicpain AT marchandfabien molecularmechanismsunderlyingtheenhancedanalgesiceffectofoxycodonecomparedtomorphineinchemotherapyinducedneuropathicpain AT dubacqsophie molecularmechanismsunderlyingtheenhancedanalgesiceffectofoxycodonecomparedtomorphineinchemotherapyinducedneuropathicpain AT mcmahonstephenb molecularmechanismsunderlyingtheenhancedanalgesiceffectofoxycodonecomparedtomorphineinchemotherapyinducedneuropathicpain AT pezetsophie molecularmechanismsunderlyingtheenhancedanalgesiceffectofoxycodonecomparedtomorphineinchemotherapyinducedneuropathicpain |